Cefazolin
| File:Cefazolin.svg | |
| Systematic (IUPAC) name | |
|---|---|
|
(6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | |
| Clinical data | |
| Pregnancy category | |
| Routes of administration | Intravenous, intramuscular |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Bioavailability | NA |
| Metabolism | ? |
| Biological half-life |
1.8 hours (given IV) 2 hours (given IM) |
| Excretion | Renal, unchanged |
| Identifiers | |
| CAS Number | 25953-19-9 |
| ATC code | J01DB04 (WHO) QJ51DA04 |
| PubChem | CID 33255 |
| DrugBank | DB01327 |
| ChemSpider | 30723 |
| Chemical data | |
| Formula | C14H14N8O4S3 |
| Molar mass | 454.51 g/mol[[Script error: No such module "String".]] |
| Script error: No such module "collapsible list". | |
| (verify) | |
Cefazolin (INN), also known as cefazoline or cephazolin, is a first-generation cephalosporin antibiotic.
The drug is usually administrated by either intramuscular injection (injection into a large muscle) or intravenous infusion (intravenous fluid into a vein).
Indications
Cefazolin is mainly used to treat bacterial infections of the skin. It can also be used to treat moderately severe bacterial infections involving the lung, bone, joint, stomach, blood, heart valve, and urinary tract. It is clinically effective against infections caused by staphylococci and streptococci of Gram-positive bacteria. These organisms are common on normal human skin. Resistance to cefazolin is seen in several species of bacteria.
Adverse effects
Adverse drug reactions from cefazolin are not common. Possible side effects include diarrhea, stomach pain or upset stomach, vomiting, and rash.
Like that of several other cephalosporins, the chemical structure of cefazolin contains an N-methylthiotetrazole (NMTT or 1-MTT) side-chain. As the antibiotic is broken down in the body, it releases free NMTT, which can cause hypoprothrombinemia (likely due to inhibition of the enzyme vitamin K epoxide reductase) and a reaction with ethanol similar to that produced by disulfiram (Antabuse), due to inhibition of aldehyde dehydrogenase.[1]
Brands
Cefazolin is marketed under the following brand names: Ancef, Cefacidal, Cefamezin, Cefrina, Elzogram, Faxilen, Gramaxin, Kefazol, Kefol, Kefzol, Kefzolan, Kezolin, Novaporin, Reflin, and Zolicef.
References
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />External links
| 50px | This systemic antibacterial-related article is a stub. You can help ssf by expanding it. |
es:Cefazolina fr:Céfazoline it:Cefazolina pl:Cefazolina pt:Cefazolina ru:Цефазолин sl:Cefazolin th:เซฟาโซลิน
zh:头孢唑啉- ↑ Stork CM (2006). "Antibiotics, antifungals, and antivirals". In Nelson LH, Flomenbaum N, Goldfrank LR, Hoffman RL, Howland MD, Lewin NA (eds.). Goldfrank's toxicologic emergencies. New York: McGraw-Hill. p. 847. ISBN 0-07-143763-0. Retrieved 2009-07-03.
- Pages with script errors
- Pages with broken file links
- Drugs with non-standard legal status
- Infobox drug tracked parameters
- Articles without EBI source
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Antibiotic stubs
- Cephalosporin antibiotics
- World Health Organization essential medicines
- Tetrazoles
- Thiadiazoles
- 2Fix
- CS1 maint: Multiple names: editors list
- CS1 maint: Extra text: editors list
